Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
With its unique dual action, exceptional effectiveness, and favorable safety profile, Tirzepatide represents a significant advancement in obesity and metabolic health management
Average weight loss in SURPASS-2 over 40 weeks: Mounjaro 5mg: 7.7 kg (17 lb) Mounjaro 10mg: 9.5 kg (21 lb) Mounjaro 15mg: 11.4 kg (25 lb) A 2025 study backs this up, in which US researchers found that tirzepatide generally led to more weight loss than semaglutide
15 September 2023 5 min read by The Conversation Many of the drugs we use today started their journey from bench to bedside in a computer
As the GLP-1 landscape continues to evolve, the goal is no longer simply deciding whether to cover these medicationsbut determining how to maximize their value for both employees and employer-sponsored health plans.
